CAPITAL MARKETS
We regularly advise issuers, underwriters and sponsors on various types of securities and corporate finance transactions in Hong Kong. These transactions include public listings, back-door listings, private and public offerings, corporate financings, corporate spin-offs, restructurings, rights issues and placings as well as the issue of derivatives, share warrants, convertible notes, bonds and options. The industries we cover include mining, medical and pharmaceutical products, bio-technology, catering, fashion, logistics, telecommunications, manufacturing, wholesale and retail, real estate, securities, investment banking and transportation. Below are some of the substantial transactions our team has advised on:
- advising Crown Landmark Corporation on its unconditional mandatory cash offer to acquire 69.9% of all the issued Shares in VXL Capital Limited (a company listed on the Hong Kong Stock Exchange) in 2014 (Takeover)
- advising VC Brokerage Limited as Hong Kong legal counsel of the Lead Manager and Bookrunner for the IPO of Ngai Shun Holdings Limited (HK Stock Code: 1246) in 2013
- advising Value Convergence Holdings Limited (a Hong Kong listed company) on the placing of non-listed warrants in 2013
- advising VC Brokerage Limited as placing agent on the placing of shares of Asia Energy Logistics Group Limited (a Hong Kong listed company) in 2013
- advising Sky Earth Limited in the mandatory unconditional general offer for Shenyang Public Utility Holdings Company Limited (a Hong Kong listed company public takeover) in 2012
- advising VC Brokerage Limited as placing agent on the open offer of China Zenith Chemical Group Limited in 2012
- advising TLT Lottotainment Group Limited (a Hong Kong listed company) on its top-up and placing transactions in January, April and August 2011
- advising China Fortune Financial Group Limited (a Hong Kong listed company) on its subscription for exchange note issued by a subsidiary of China Credit Holdings Limited (a Hong Kong listed company) in 2011
- advising China Grand Pharmaceutical and Healthcare Holdings Limited (a Hong Kong listed company) on its rights issue in 2010